One obstacle to epilepsy research is limited representation in diagnostic coding systems like the International Classification of Diseases (ICD) system. Only a few entities appear in versions 9 and 10, such as tuberous sclerosis (ICD‐9‐CM 759.5, ICD‐10 Q85.1) and infantile spasms (ICD‐9‐CM 345.6, ICD‐10 G40.82). Although version 10 adds juvenile myoclonic epilepsy (G40.B), absence epilepsy (G40.A), and Lennox‐Gastaut syndrome (G40.81), many rare epilepsies appear in neither system. For example, Dravet syndrome is coded with the nonspecific ICD‐9 345.1 "Generalized Convulsive Epilepsy" or ICD‐10 G40.4 "Other generalized epilepsy and epileptic syndromes." This limits the utility of large administrative and clinical datasets for epilepsy research, despite the clear value of such data for research in epidemiology, comparative effectiveness, health services, and quality improvement.[1](#epi412095-bib-0001){ref-type="ref"}

Given the increasing availability of electronic health records for research, computerized analysis of clinical notes may be useful for finding patients with specific epilepsy syndromes. For example, text processing can identify children with complex febrile seizures,[2](#epi412095-bib-0002){ref-type="ref"} and natural language processing can identify candidates for epilepsy surgery.[3](#epi412095-bib-0003){ref-type="ref"}

One challenge for using these techniques is the diversity of terms for epilepsies. Dravet syndrome, for example, is "severe myoclonic epilepsy of infancy" for some clinicians and "intractable childhood epilepsy with generalized tonic clonic seizures" for others. Although existing standardized medical vocabularies document some synonyms, many vocabularies have gaps. For example, OMIM (Online Mendelian Inheritance in Man) lacks well‐defined entries for infantile spasms, Lennox‐Gastaut syndrome, and migrating partial seizures of infancy.

To facilitate the development of text and natural language processing tools for epilepsy, we compiled synonyms and associated terms for 33 rare epilepsies, with links to 3 standard medical vocabularies.

Methods {#epi412095-sec-0002}
=======

Study design {#epi412095-sec-0003}
------------

We compiled synonyms and associated terms for rare epilepsies via 6 sources: a survey of pediatric neurology clinicians ("provider survey"), a survey of caregivers of individuals with rare epilepsies ("caregiver survey"), manual review of online resources, a manual review of 3 structured medical vocabularies, correspondence with leaders of rare epilepsy advocacy groups, and independent clinician review. We selected 33 rare epilepsies based on the parent‐led advocacy groups that constitute the Rare Epilepsy Network (REN; ren.rti.org), an umbrella organization that fosters research collaboration.

Surveys {#epi412095-sec-0004}
-------

For each survey, we designed, piloted, and iteratively refined questions using online software (SurveyMonkey, Inc., San Mateo, CA, U.S.A.). The "provider survey" was distributed to members of the Child Neurology Society (CNS) via email. Five versions were distributed, each asking respondents to list synonyms for 5--6 of the 33 epilepsies. The "caregiver survey" was distributed to REN participants. It asked respondents to name the epilepsy affecting the individual, and then list synonyms used by clinicians and family members.

Websites {#epi412095-sec-0005}
--------

One investigator (ZG) manually reviewed several websites for more synonyms and associated terms. These included websites focused on epilepsy (epilepsy.com, dup15q.org), rare diseases (rarediseases.org, rarechromo.org, and ghr.nlm.nih.gov), and general knowledge (wikipedia.com).

Vocabularies {#epi412095-sec-0006}
------------

Two investigators (ZG and BH) manually reviewed 3 standardized vocabularies: OrphaNet ([www.orpha.net](http://www.orpha.net)), Unified Medical Language System (UMLS) Metathesaurus (utslogin.nlm.nih.gov/cas/login), and Systematized Nomenclature of Medicine Clinical Terms (SNOMED‐CT; browser.ihtsdotools.org). In SNOMED‐CT and UMLS, we included terms and subterms (ie, "infantile spasms" and "refractory infantile spasms") as well as pathognomonic physical examination findings ("Ash leaf spot, tuberous sclerosis"). We limited the search to terms in English.

Advocacy groups {#epi412095-sec-0007}
---------------

We individually contacted advocacy group leaders via email. Each email contained a working list of synonyms and associated terms for the specified epilepsy, and asked the group leader to review, amend, and/or expand the list.

Clinical experts {#epi412095-sec-0008}
----------------

Five clinical pediatric epilepsy specialists (EY, TM, PM, AN, and SW) reviewed the drafted compendium and made additional recommendations and edits.

Synonyms and associated terms {#epi412095-sec-0009}
-----------------------------

We reviewed terms that were synonymous with a rare epilepsy (eg, "Dimitri disease" for Sturge‐Weber), as well as terms specific to a rare epilepsy, but better characterized as an "associated term." For example, "shagreen patch" is specific to tuberous sclerosis, but is not a synonym. In addition, we reviewed terms that were not specific to one type of epilepsy ("intractable"). We sorted terms into 3 categories (synonyms, associated terms, and nonspecific) as determined jointly by 2 of the authors (ZG and DH). Disagreements were rare, and were resolved through discussion. We included only synonyms and associated terms.

Results {#epi412095-sec-0010}
=======

There were 160 respondents to the provider survey of the 1982 emailed CNS members (response rate 8%). These included 107 (67%) pediatric neurologists, 40 (25%) pediatric epilepsy specialists, and 13 (8%) other clinicians (ie, nurse, nurse practitioners, adult epilepsy specialist, physician assistant, EEG technician, or medical student). Twenty‐six (16%) were physician trainees (ie, residents or fellows). Most worked in the United States (153; 96%), including responses from 33 states and the District of Columbia. The 7 international responses were from Canada (5), Lebanon (1), and the United Kingdom (1).

There were 375 respondents to the caregiver survey, of 1162 members of the REN (response rate 32%). Most (356; 95%) were parents of an individual with epilepsy. The remainder included 2 individuals with rare epilepsy (both progressive myoclonic epilepsy), 4 unspecified caregivers, and 13 unknown (left blank). The majority lived in the United States (319; 85%), including 48 states (none from Alaska or North Dakota). There were 55 responses from 20 countries, and 1 unknown.

Leaders of 11 advocacy groups added more terms for the following disorders: Aicardi syndrome, Doose syndrome, Dravet syndrome, hypothalamic hamartoma, Lennox‐Gastaut syndrome, PCDH19, Phelan‐McDermid syndrome, Ring chromosome 20, *SCN8A*,*SYNGAP*, and tuberous sclerosis.

The final list included all 33 rare epilepsies (Table [1](#epi412095-tbl-0001){ref-type="table-wrap"}), including 16 defined by phenotype and 17 by genotype. Across all 33 rare epilepsies, there was a median of 14 synonyms (range 6--28). Fifteen had no associated terms. The remaining 19 epilepsies had a median of 4 associated terms (range 1--41). For example, Aicardi syndrome had 6 synonyms (AS, Aicardi\'s syndrome, Aicardi disease, Aicardi\'s disease, Aicardi, and Aicardi\'s) and 12 associated terms (microcephaly, retinal lacunae, agenesis of corpus callosum, absent corpus callosum, infantile spasms, polymicrogyria, porencephalic cysts, coloboma, optic disc, ACC, retinal lesions, and lacunae) (Table [S1](#epi412095-sup-0001){ref-type="supplementary-material"}).

###### 

Number of synonyms, associated terms, and entries in standardized medical vocabularies for 33 rare epilepsies

  Category                                         Rare epilepsy                       Synonyms   Associated terms   SNOMED‐CT entries   OrphaNet entries   UMLS meta‐thesaurus
  ------------------------------------------------ ----------------------------------- ---------- ------------------ ------------------- ------------------ ---------------------
  Epilepsies primarily defined by phenotype        Aicardi syndrome                    6          12                 1                   1                  1
  Doose syndrome                                   20                                  0          1                  1                   1                  
  Dravet syndrome                                  27                                  0          1                  1                   3                  
  Holoprosencephaly                                10                                  5          1                  1                   1                  
  Hypothalamic hamartoma                           12                                  13         1                  1                   2                  
  Infantile spasms                                 9                                   8          6                  1                   18                 
  Landau‐Kleffner                                  18                                  0          1                  1                   3                  
  Lennox‐Gastaut syndrome                          8                                   2          1                  1                   11                 
  Migrating partial seizures of infancy            15                                  0          1                  1                   3                  
  Myoclonic epilepsy with ragged red fibers        20                                  2          1                  1                   3                  
  Neuronal ceroid lipofuscinosis                   25                                  1          1                  7                   25                 
  Ohtahara syndrome                                8                                   0          1                  1                   3                  
  Rasmussen syndrome                               9                                   1          1                  1                   3                  
  Rett syndrome                                    17                                  2          1                  1                   5                  
  Sturge‐Weber                                     16                                  6          1                  1                   2                  
  Tuberous sclerosis                               10                                  41         4                  1                   7                  
  Epilepsies primarily defined by genotype         Alpers disease (*POLG* mutations)   25         1                  1                   1                  1
  Angelman syndrome                                13                                  0          1                  7                   1                  
  Epilepsy due to *CDKL5* mutations                19                                  0          0                  1                   3                  
  Dup15q                                           13                                  0          0                  1                   2                  
  Fragile X syndrome                               17                                  8          1                  1                   1                  
  Glut1 deficiency                                 17                                  0          0                  1                   1                  
  *KCNQ2* Encephalopathy                           28                                  0          0                  1                   2                  
  PCDH19                                           21                                  0          1                  1                   2                  
  Phelan‐McDermid                                  13                                  25         1                  1                   1                  
  Prader Willi                                     15                                  3          1                  1                   1                  
  Ring chromosome 14                               6                                   0          1                  1                   1                  
  Ring chromosome 20                               15                                  0          1                  1                   1                  
  *SCN2A* encephalopathy                           18                                  4          0                  1                   2                  
  *SCN8A* encephalopathy                           13                                  0          0                  1                   2                  
  Epilepsy due to *SLC13A5* mutations              8                                   0          0                  0                   1                  
  Epilepsy due to *SYNGAP* mutations               9                                   17         0                  1                   1                  
  Unverricht‐Lundborg Disease (*CSTB* mutations)   14                                  0          1                  1                   1                  
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The UMLS‐Metathesaurus had entries for all 33 epilepsies. Half (15) had 1 entry; the remaining had multiple entries, including 11 for Lennox‐Gastaut syndrome, 18 for infantile spasms, and 25 for neuronal ceroid lipofuscinosis. Several entries were redundant---for example, there were 7 entries with overlapping descriptions of "refractory infantile spasms," and 2 nearly identical entries for nonrefractory Lennox‐Gastaut syndrome (Table [2](#epi412095-tbl-0002){ref-type="table-wrap"}). Five epilepsies (*KCNQ2*,*SCN2A*,*SCN8A*,*SYNGAP*, and *SLC13A5*) were not linked to disease entities, but rather to entries entitled "Caused by a mutation in \[gene\]."

###### 

Examples of deficiencies in standard medical vocabularies

  Deficiency                                                                           Clinical concept                                                                                                                 Vocabulary                                                                                                                                     Terms
  ------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------
  Redundancy                                                                           Lennox‐Gastaut syndrome, not intractable                                                                                         UMLS Metathesaurus                                                                                                                             C3648103 "Lennox‐Gastaut syndrome, not intractable"
  C3494904 "Lennox‐Gastaut syndrome, non‐refractory"                                                                                                                                                                                                                                                                                                                   
  Infantile spasms, Intractable                                                        UMLS Metathesaurus                                                                                                               C0154716 "Infantile spasms, with intractable epilepsy"                                                                                         
  C1827396 "Refractory infantile spasms"                                                                                                                                                                                                                                                                                                                               
  C2712779 "Infantile spasms, poorly controlled"                                                                                                                                                                                                                                                                                                                       
  C2712780 "Infantile spasms, refractory (medically)"                                                                                                                                                                                                                                                                                                                  
  C2712781 "Infantile spasms, pharmacologically resistant"                                                                                                                                                                                                                                                                                                             
  C2712782 "Infantile spasms, treatment resistant"                                                                                                                                                                                                                                                                                                                     
  C3648801 "Infantile spasms with intractable epilepsy with status epilepticus"                                                                                                                                                                                                                                                                                        
  C3837134 "Infantile spasms, with intractable epilepsy, without status epilepticus"                                                                                                                                                                                                                                                                                   
  No phenotype                                                                         *SCN2A* encephalopathy                                                                                                           OrphaNet                                                                                                                                       ORPHA118500 "*SCN2A*---sodium voltage‐gated channel alpha subunit 2"
  UMLS Metathesaurus                                                                   C3277014 "Caused by mutation in the alpha‐1‐subunit of the voltage‐gated type II sodium channel gene (*SCN2A*, 182390.0002)"                                                                                                                                                    
  UMLS Metathesaurus                                                                   C3279128 "Caused by mutation in the voltage‐gated, type II sodium channel, alpha subunit (*SCN2A*, 182390.0008)"                                                                                                                                                                
  *SCN8A* encephalopathy                                                               UMLS Metathesaurus                                                                                                               C3280426 "Caused by mutation in the voltage‐gated sodium channel, type VIII, alpha subunit gene (*SCN8A*, 600702.0001)"                        
  UMLS Metathesaurus                                                                   C3553209 "Caused by mutation in the voltage‐gated sodium channel, type VIII, alpha subunit gene (*SCN8A*, 600702.0002)"                                                                                                                                                         
  Epilepsy due to *SYNGAP*                                                             UMLS Metathesaurus                                                                                                               C3808213 "Caused by mutation in the synaptic Ras GTPase activating protein 1 gene (*SYNGAP1*, 603384.0001)"                                    
  Epilepsy due to *SLC13A5*                                                            UMLS Metathesaurus                                                                                                               C4014623 "Caused by mutation in the solute carrier family 13 (sodium‐dependent citrate transporter), member 5 gene (*SLC13A5*, 608305.0001)"   
  *KCNQ2* encephalopathy                                                               UMLS Metathesaurus                                                                                                               C1852593 "Caused by mutation in the potassium voltage‐gated channel, KQT‐like subfamily, member 2 gene (*KCNQ2*, 602235.0001)"                 
  UMLS Metathesaurus                                                                   C3279124 "Caused by mutation in the voltage‐gated potassium channel, KQT‐like subfamily, member 2 gene (*KCNQ2*, 602235.0007)"                                                                                                                                                  
  No entry                                                                             *CDKL5* mutations                                                                                                                SNOMED‐CT                                                                                                                                      (missing)
  Dup15q syndrome                                                                      SNOMED‐CT                                                                                                                        (missing)                                                                                                                                      
  Glut1 deficiency                                                                     SNOMED‐CT                                                                                                                        (missing)                                                                                                                                      
  *KCNQ2* encephalopathy                                                               SNOMED‐CT                                                                                                                        (missing)                                                                                                                                      
  *SCN2A* encephalopathy                                                               SNOMED‐CT                                                                                                                        (missing)                                                                                                                                      
  *SCN8A* encephalopathy                                                               SNOMED‐CT                                                                                                                        (missing)                                                                                                                                      
  Epilepsy due to *SYNGAP*                                                             SNOMED‐CT                                                                                                                        (missing)                                                                                                                                      
  Epilepsy due to *SLC13A5*                                                            SNOMED‐CT                                                                                                                        (missing)                                                                                                                                      
  Epilepsy due to *SLC13A5*                                                            OrphaNet                                                                                                                         (missing)                                                                                                                                      
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OrphaNet had entries for 32 epilepsies. The missing epilepsy (*SLC13A5*) was linked with "ORPHA442835 Undetermined early‐onset epileptic encephalopathy" but did not have its own entry. Three contained information about the relevant gene (*SCN2A*,*SCN8A*, and *SYNGAP*) only, without phenotype information (Table [2](#epi412095-tbl-0002){ref-type="table-wrap"}). Thirty had 1 entry, 2 had 7 entries: Angelman syndrome and neuronal ceroid lipofuscinosis.

SNOMED‐CT had entries for 25 rare epilepsies (missing: *CDKL5*, Dup15q Syndrome, Glut1 deficiency, *KCNQ2*,*SCN2A*,*SCN8A*,*SLC13A5*, and *SYNGAP*; Table [2](#epi412095-tbl-0002){ref-type="table-wrap"}). Of these 25 rare epilepsies, 2 had multiple entries (6 for infantile spasms and 4 for tuberous sclerosis).

Discussion {#epi412095-sec-0011}
==========

Summary {#epi412095-sec-0012}
-------

We compiled synonyms and associated terms for 33 rare epilepsies, including links to 3 standardized vocabularies. The compilation is available freely online. There are gaps in these vocabularies, including poor representation of emerging epilepsies (eg, *SCN2A*,*SCN8A*,*SYNGAP*,*KCNQ2*, and *SLC13A5*), and redundancies of clinical concepts (treatment resistance).

Significance {#epi412095-sec-0013}
------------

This work builds an important resource to help clinicians and researchers find epilepsy subpopulations in electronic health record systems. Currently, to collect large cohorts of children with epilepsy, clinical researchers are building registries via recruitment of patients one by one in clinical settings.[4](#epi412095-bib-0004){ref-type="ref"} In contrast, text processing and/or natural language processing tools can quickly identify cohorts for observational research and clinical trials. Such tools may also support care coordination and quality improvement initiatives.

Three examples follow. First, case finding may be possible with simple text searches of clinical notes. This approach was used successfully (in combination with chart review) to identify children with febrile seizures.[2](#epi412095-bib-0002){ref-type="ref"} However, simple text search may fail when terms are ambiguous ("SCN1A pending"), negated ("SCN1A testing unrevealing"), or included in boilerplate text ("Our epilepsy gene panel includes SCN1A, SCN1B, *SCN2A*..."). Second, customized natural language processing algorithms may be developed for specific populations. For example, in epilepsy, recent work identified surgical candidates by applying support vector machines to the text of physician notes.[3](#epi412095-bib-0003){ref-type="ref"} Similar work in cardiology can identify individuals with heart failure.[5](#epi412095-bib-0005){ref-type="ref"} However, such algorithms are often tailored to a single center, and may be difficult to disseminate. Third, published epilepsy classification systems[6](#epi412095-bib-0006){ref-type="ref"}, [7](#epi412095-bib-0007){ref-type="ref"} and ontologies[8](#epi412095-bib-0008){ref-type="ref"} could be integrated into existing natural language processing systems.[9](#epi412095-bib-0009){ref-type="ref"} This approach would require evaluation of baseline performance, identification of gaps (as we have done here), and ongoing review and maintenance.

The specific deficiencies in currently available vocabularies merit additional commentary. The phenotype of *SCN2A* encephalopathy[10](#epi412095-bib-0010){ref-type="ref"} and *SCN8A* encephalopathy[11](#epi412095-bib-0011){ref-type="ref"} are only beginning to emerge, largely based on international registry data. These phenotypes should be incorporated into the existing medical informatics infrastructure to support ongoing research into these diseases. In contrast, the epilepsies associated with *SLC13A5* [12](#epi412095-bib-0012){ref-type="ref"} and *SYNGAP1* [13](#epi412095-bib-0013){ref-type="ref"} are described only through small case series. Their full phenotype is not well understood.

Finally, redundancies in the epilepsy vocabularies can reduce their utility. Redundancies make it harder to use and maintain a structured vocabulary, and erode the premise that a one‐to‐one relationship ties each clinical concept to a term.[14](#epi412095-bib-0014){ref-type="ref"} For example, the redundant entries for "treatment resistance" is particularly important, given that (1) research often focuses on this population, and (2) treatment‐resistant patients may benefit from referral to a comprehensive epilepsy center.

Limitations {#epi412095-sec-0014}
-----------

First, our selection of rare epilepsies was guided by patient advocacy groups, each of which is unified by a specific feature of the affected individuals; for some a gene, and others a clinical phenotype. This may cause some individuals to be classified in multiple groups. *PCDH19* mutations, for example, may cause the clinical phenotype of Dravet syndrome. Second, the survey respondents were largely US based, and the terms were limited to the English language. Further work is required to add non--English‐language terms. Third, language evolves over time. Thus the compendium will need updating as terms arise or fade. Fourth, we selected only a subset of several hundred rare epilepsies.[15](#epi412095-bib-0015){ref-type="ref"} Fifth, the survey response rates were low. However, we generated a robust list of terms by supplementing the 2 surveys with other sources, thereby meeting the study objectives. Finally, our work is silent on how terms are used in clinical practice. Further work is needed to describe how terms appear in clinical notes to understand their value for case finding.

Conclusions {#epi412095-sec-0015}
===========

Epilepsy terms in structured medical vocabularies have gaps and redundancies, which should be addressed. These collected terms may help researchers and clinicians find individuals with rare epilepsies in electronic data sources. Further work is needed to evaluate their utility in identifying affected individuals.
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